CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $414,178 | -23.9% | 14,059 | -15.7% | 0.00% | -50.0% |
| Q2 2023 | $544,036 | +138.6% | 16,678 | +235.1% | 0.00% | +100.0% |
| Q4 2022 | $228,046 | +119.3% | 4,977 | +131.1% | 0.00% | – |
| Q3 2022 | $104,000 | -73.3% | 2,154 | -79.6% | 0.00% | – |
| Q1 2022 | $389,000 | -89.9% | 10,580 | -87.4% | 0.00% | -100.0% |
| Q4 2021 | $3,839,000 | +284.3% | 84,220 | +66.9% | 0.00% | +200.0% |
| Q2 2021 | $999,000 | +33.9% | 50,455 | +57.3% | 0.00% | 0.0% |
| Q1 2021 | $746,000 | +16.0% | 32,077 | +3.6% | 0.00% | 0.0% |
| Q4 2020 | $643,000 | +47.1% | 30,948 | +53.4% | 0.00% | 0.0% |
| Q3 2020 | $437,000 | +5362.5% | 20,169 | +2831.5% | 0.00% | – |
| Q3 2019 | $8,000 | -78.4% | 688 | -79.2% | 0.00% | – |
| Q2 2019 | $37,000 | +208.3% | 3,315 | +119.8% | 0.00% | – |
| Q1 2019 | $12,000 | -96.7% | 1,508 | -96.0% | 0.00% | -100.0% |
| Q3 2018 | $367,000 | -22.1% | 37,272 | -34.3% | 0.00% | -25.0% |
| Q2 2018 | $471,000 | +86.9% | 56,714 | +61.8% | 0.00% | +33.3% |
| Q1 2018 | $252,000 | +5.4% | 35,050 | +19.4% | 0.00% | +50.0% |
| Q4 2017 | $239,000 | -75.1% | 29,364 | -55.5% | 0.00% | -77.8% |
| Q3 2017 | $958,000 | +190.3% | 66,057 | +142.3% | 0.01% | +200.0% |
| Q2 2017 | $330,000 | +17.9% | 27,260 | +25.0% | 0.00% | 0.0% |
| Q1 2017 | $280,000 | +10.7% | 21,813 | +4.8% | 0.00% | +50.0% |
| Q4 2016 | $253,000 | +3.3% | 20,810 | -22.0% | 0.00% | -33.3% |
| Q3 2016 | $245,000 | +97.6% | 26,671 | +104.6% | 0.00% | +200.0% |
| Q2 2016 | $124,000 | -52.5% | 13,034 | -47.7% | 0.00% | -66.7% |
| Q4 2015 | $261,000 | +51.7% | 24,927 | -3.2% | 0.00% | +50.0% |
| Q3 2015 | $172,000 | -2.8% | 25,743 | -2.5% | 0.00% | 0.0% |
| Q2 2015 | $177,000 | +284.8% | 26,391 | +362.2% | 0.00% | +100.0% |
| Q4 2014 | $46,000 | -90.9% | 5,710 | -96.0% | 0.00% | -87.5% |
| Q3 2014 | $508,000 | -61.7% | 144,210 | -48.0% | 0.01% | -60.0% |
| Q2 2014 | $1,327,000 | -27.0% | 277,531 | +45.1% | 0.02% | -35.5% |
| Q1 2014 | $1,817,000 | +1170.6% | 191,268 | +769.7% | 0.03% | +1450.0% |
| Q4 2013 | $143,000 | – | 21,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |